nsi-189
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2011 (NCT01310881)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)CCNc1ncccc1C(=O)N1CCN(Cc2ccccc2)CC1- Mol. weight
- 366.51 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4302505 ↗
Also known as
- nsi-189
- nsi-189
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02695472 | Phase 2 | Mar 1, 2016 | Seneca Biopharma, Inc. |
| NCT01520649 | Phase 1 | May 1, 2012 | Seneca Biopharma, Inc. |
| NCT01310881 | Phase 1 | Feb 1, 2011 | California Clinical Trials, Seneca Biopharma, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Seneca Biopharma, Inc. | For profit | 3 | 3 | 2 | 2011 |
| California Clinical Trials | For profit | 1 | 0 | 1 | 2011 |
2 organizations
Page 1 / 1